 | • レポートコード：QY20ST-06947 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の五価アンチモニアル市場について種類別（スチボグルコン酸ナトリウム、アンチモン酸メグルミン）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・五価アンチモニアル市場の概要 ・世界の主要地域別五価アンチモニアル市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の五価アンチモニアル市場規模2015-2026：種類別（スチボグルコン酸ナトリウム、アンチモン酸メグルミン） ・世界の五価アンチモニアル市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・五価アンチモニアルの北米市場規模2015-2020 ・五価アンチモニアルのヨーロッパ市場規模2015-2020 ・五価アンチモニアルの中国市場規模2015-2020 ・五価アンチモニアルの日本市場規模2015-2020 ・五価アンチモニアルの東南アジア市場規模2015-2020 ・五価アンチモニアルのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・五価アンチモニアルの製造コスト分析 ・販売チャネル、流通業者、顧客 ・五価アンチモニアルの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Pentavalent Antimonials Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Pentavalent Antimonials market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Pentavalent Antimonials, also called pentavalent antimony compounds, are used to treat patients with leishmaniasis, but they have collateral effects and, in some cases, low cure rate. The compounds currently available for clinical use are: sodium stibogluconate and meglumine antimoniate. Pentavalent antimonials can only be given by injection.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pentavalent Antimonials market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pentavalent Antimonials industry.
Based on our recent survey, we have several different scenarios about the Pentavalent Antimonials YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Pentavalent Antimonials will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Pentavalent Antimonials market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Pentavalent Antimonials market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Pentavalent Antimonials market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Pentavalent Antimonials market. The report also includes nautical information, where it shows Pentavalent Antimonials market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Pentavalent Antimonials market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Pentavalent Antimonials market.
Geographical Analysis:
Based on region, the global Pentavalent Antimonials market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Pentavalent Antimonials market are
Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct
…
Segment by Type
Sodium Stibogluconate
Meglumine Antimoniate
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Pentavalent Antimonials market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Pentavalent Antimonials market.
• The market share of the global Pentavalent Antimonials market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Pentavalent Antimonials market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Pentavalent Antimonials market.
1 Pentavalent Antimonials Market Overview
1.1 Pentavalent Antimonials Product Scope
1.2 Pentavalent Antimonials Segment by Type
1.2.1 Global Pentavalent Antimonials Sales by Type (2020-2026)
1.2.2 Sodium Stibogluconate
1.2.3 Meglumine Antimoniate
1.3 Pentavalent Antimonials Segment by Application
1.3.1 Global Pentavalent Antimonials Sales Comparison by Application (2020-2026)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Pentavalent Antimonials Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pentavalent Antimonials Sales Growth Rate (2015-2026)
1.4.2 Global Pentavalent Antimonials Revenue and Growth Rate (2015-2026)
1.4.3 Global Pentavalent Antimonials Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pentavalent Antimonials Industry Impact
1.5.1 How the Covid-19 is Affecting the Pentavalent Antimonials Industry
1.5.1.1 Pentavalent Antimonials Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pentavalent Antimonials Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pentavalent Antimonials Players to Combat Covid-19 Impact
2 Pentavalent Antimonials Estimate and Forecast by Region
2.1 Global Pentavalent Antimonials Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pentavalent Antimonials Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pentavalent Antimonials Sales Market Share by Region (2015-2020)
2.2.2 Global Pentavalent Antimonials Revenue Market Share by Region (2015-2020)
2.3 Global Pentavalent Antimonials Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pentavalent Antimonials Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pentavalent Antimonials Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pentavalent Antimonials Estimates and Projections (2015-2026)
2.4.2 Europe Pentavalent Antimonials Estimates and Projections (2015-2026)
2.4.3 China Pentavalent Antimonials Estimates and Projections (2015-2026)
2.4.4 Japan Pentavalent Antimonials Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pentavalent Antimonials Estimates and Projections (2015-2026)
2.4.6 India Pentavalent Antimonials Estimates and Projections (2015-2026)
3 Global Pentavalent Antimonials Competition Landscape by Players
3.1 Global Top Pentavalent Antimonials Players by Sales (2015-2020)
3.2 Global Top Pentavalent Antimonials Players by Revenue (2015-2020)
3.3 Global Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pentavalent Antimonials as of 2019)
3.4 Global Pentavalent Antimonials Average Price by Company (2015-2020)
3.5 Manufacturers Pentavalent Antimonials Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pentavalent Antimonials Players (Opinion Leaders)
4 Global Pentavalent Antimonials Market Size by Type
4.1 Global Pentavalent Antimonials Historic Market Review by Type (2015-2020)
4.1.1 Global Pentavalent Antimonials Sales Market Share by Type (2015-2020)
4.1.2 Global Pentavalent Antimonials Revenue Market Share by Type (2015-2020)
4.1.3 Global Pentavalent Antimonials Price by Type (2014-2020)
4.2 Global Pentavalent Antimonials Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pentavalent Antimonials Sales Forecast by Type (2021-2026)
4.2.2 Global Pentavalent Antimonials Revenue Forecast by Type (2021-2026)
4.2.3 Global Pentavalent Antimonials Price Forecast by Type (2021-2026)
5 Global Pentavalent Antimonials Market Size by Application
5.1 Global Pentavalent Antimonials Historic Market Review by Application (2015-2020)
5.1.1 Global Pentavalent Antimonials Sales Market Share by Application (2015-2020)
5.1.2 Global Pentavalent Antimonials Revenue Market Share by Application (2015-2020)
5.1.3 Global Pentavalent Antimonials Price by Application (2015-2020)
5.2 Global Pentavalent Antimonials Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pentavalent Antimonials Sales Forecast by Application (2021-2026)
5.2.2 Global Pentavalent Antimonials Revenue Forecast by Application (2021-2026)
5.2.3 Global Pentavalent Antimonials Price Forecast by Application (2021-2026)
3 North America Pentavalent Antimonials Market Facts & Figures
3.2 North America Pentavalent Antimonials Sales Market Share by Company (2015-2020)
3.3 North America Pentavalent Antimonials Sales Market Share by Type (2015-2020)
3.4 North America Pentavalent Antimonials Sales Market Share by Application (2015-2020)
4 Europe Pentavalent Antimonials Market Facts & Figures
4.2 Europe Pentavalent Antimonials Sales Market Share by Company (2015-2020)
4.3 Europe Pentavalent Antimonials Sales Market Share by Type (2015-2020)
4.4 Europe Pentavalent Antimonials Sales Market Share by Application (2015-2020)
5 China Pentavalent Antimonials Market Facts & Figures
5.2 China Pentavalent Antimonials Sales Market Share by Company (2015-2020)
5.3 China Pentavalent Antimonials Sales Market Share by Type (2015-2020)
5.4 China Pentavalent Antimonials Sales Market Share by Application (2015-2020)
6 Japan Pentavalent Antimonials Market Facts & Figures
6.2 Japan Pentavalent Antimonials Sales Market Share by Company (2015-2020)
6.3 Japan Pentavalent Antimonials Sales Market Share by Type (2015-2020)
6.4 Japan Pentavalent Antimonials Sales Market Share by Application (2015-2020)
7 Southeast Asia Pentavalent Antimonials Market Facts & Figures
7.2 Southeast Asia Pentavalent Antimonials Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pentavalent Antimonials Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pentavalent Antimonials Sales Market Share by Application (2015-2020)
8 India Pentavalent Antimonials Market Facts & Figures
8.2 India Pentavalent Antimonials Sales Market Share by Company (2015-2020)
8.3 India Pentavalent Antimonials Sales Market Share by Type (2015-2020)
8.4 India Pentavalent Antimonials Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pentavalent Antimonials Business
12.1 Sanofi
12.1.1 Sanofi Pentavalent Antimonials Corporation Information
12.1.2 Sanofi Pentavalent Antimonials Business Overview and Total Revenue
12.1.3 Sanofi Pentavalent Antimonials Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Pentavalent Antimonials Products Offered
12.1.5 Sanofi Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Pentavalent Antimonials Corporation Information
12.2.2 GlaxoSmithKline Pentavalent Antimonials Business Overview and Total Revenue
12.2.3 GlaxoSmithKline Pentavalent Antimonials Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Pentavalent Antimonials Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Pentavalent Antimonials Corporation Information
12.3.2 Bristol-Myers Squibb Pentavalent Antimonials Business Overview and Total Revenue
12.3.3 Bristol-Myers Squibb Pentavalent Antimonials Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bristol-Myers Squibb Pentavalent Antimonials Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Maiden Pharmaceuticals
12.4.1 Maiden Pharmaceuticals Pentavalent Antimonials Corporation Information
12.4.2 Maiden Pharmaceuticals Pentavalent Antimonials Business Overview and Total Revenue
12.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Maiden Pharmaceuticals Pentavalent Antimonials Products Offered
12.4.5 Maiden Pharmaceuticals Recent Development
12.5 Xinhua Pharm
12.5.1 Xinhua Pharm Pentavalent Antimonials Corporation Information
12.5.2 Xinhua Pharm Pentavalent Antimonials Business Overview and Total Revenue
12.5.3 Xinhua Pharm Pentavalent Antimonials Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Xinhua Pharm Pentavalent Antimonials Products Offered
12.5.5 Xinhua Pharm Recent Development
12.6 Albert David
12.6.1 Albert David Pentavalent Antimonials Corporation Information
12.6.2 Albert David Pentavalent Antimonials Business Overview and Total Revenue
12.6.3 Albert David Pentavalent Antimonials Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Albert David Pentavalent Antimonials Products Offered
12.6.5 Albert David Recent Development
12.7 Science Direct
12.7.1 Science Direct Pentavalent Antimonials Corporation Information
12.7.2 Science Direct Pentavalent Antimonials Business Overview and Total Revenue
12.7.3 Science Direct Pentavalent Antimonials Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Science Direct Pentavalent Antimonials Products Offered
12.7.5 Science Direct Recent Development
…
13 Pentavalent Antimonials Manufacturing Cost Analysis
13.1 Pentavalent Antimonials Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pentavalent Antimonials
13.4 Pentavalent Antimonials Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pentavalent Antimonials Distributors List
14.3 Pentavalent Antimonials Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pentavalent Antimonials Sales (g) Growth Rate by Type (2020-2026)
Table 2. Global Pentavalent Antimonials Sales (g) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pentavalent Antimonials Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pentavalent Antimonials Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pentavalent Antimonials Players to Combat Covid-19 Impact
Table 8. Global Market Pentavalent Antimonials Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pentavalent Antimonials Sales (g) by Region (2015-2020)
Table 10. Global Pentavalent Antimonials Sales Market Share by Region (2015-2020)
Table 11. Global Pentavalent Antimonials Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pentavalent Antimonials Revenue Share by Region (2015-2020)
Table 13. Global Pentavalent Antimonials Sales (g) Forecast by Region (2021-2026)
Table 14. Global Pentavalent Antimonials Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pentavalent Antimonials Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pentavalent Antimonials Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pentavalent Antimonials (g) of Key Companies (2015-2020)
Table 18. Global Pentavalent Antimonials Sales Share by Company (2015-2020)
Table 19. Global Pentavalent Antimonials Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pentavalent Antimonials Revenue Share by Company (2015-2020)
Table 21. Global Pentavalent Antimonials by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pentavalent Antimonials as of 2019)
Table 22. Global Pentavalent Antimonials Average Price (USD/mg) of Key Company (2015-2020)
Table 23. Manufacturers Pentavalent Antimonials Manufacturing Sites and Area Served
Table 24. Manufacturers Pentavalent Antimonials Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pentavalent Antimonials Players
Table 27. Global Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 28. Global Pentavalent Antimonials Sales Share by Type (2015-2020)
Table 29. Global Pentavalent Antimonials Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pentavalent Antimonials Price (g) by Type (2015-2020)
Table 31. Global Pentavalent Antimonials Sales Share by Type (2021-2026)
Table 32. Global Pentavalent Antimonials Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pentavalent Antimonials Revenue Share by Type (2021-2026)
Table 34. Global Pentavalent Antimonials Price (g) by Type (2021-2026)
Table 35. Global Pentavalent Antimonials Sales (g) by Application (2015-2020)
Table 36. Global Pentavalent Antimonials Sales Share by Application (2015-2020)
Table 37. Global Pentavalent Antimonials Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pentavalent Antimonials Price (g) by Application (2015-2020)
Table 39. Global Pentavalent Antimonials Sales (g) by Application (2021-2026)
Table 40. Global Pentavalent Antimonials Sales Share by Application (2021-2026)
Table 41. Global Pentavalent Antimonials Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pentavalent Antimonials Revenue Share by Application (2021-2026)
Table 43. Global Pentavalent Antimonials Price (g) by Application (2021-2026)
Table 44. United States Pentavalent Antimonials Sales (g) by Company (2015-2020)
Table 45. United States Pentavalent Antimonials Sales Market Share by Company (2015-2020)
Table 46. United States Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 47. United States Pentavalent Antimonials Sales Market Share by Type (2015-2020)
Table 48. United States Pentavalent Antimonials Sales (g) by Application (2015-2020)
Table 49. United States Pentavalent Antimonials Sales Market Share by Application (2015-2020)
Table 50. Europe Pentavalent Antimonials Sales (g) by Company (2015-2020)
Table 51. Europe Pentavalent Antimonials Sales Market Share by Company (2015-2020)
Table 52. Europe Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 53. Europe Pentavalent Antimonials Sales Market Share by Type (2015-2020)
Table 54. Europe Pentavalent Antimonials Sales (g) by Application (2015-2020)
Table 55. Europe Pentavalent Antimonials Sales Market Share by Type (2015-2020)
Table 56. China Pentavalent Antimonials Sales (g) by Company (2015-2020)
Table 57. China Pentavalent Antimonials Sales Market Share by Company (2015-2020)
Table 58. China Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 59. China Pentavalent Antimonials Sales Market Share by Type (2015-2020)
Table 60. China Pentavalent Antimonials Sales (g) by Application (2015-2020)
Table 61. China Pentavalent Antimonials Sales Market Share by Application (2015-2020)
Table 62. Japan Pentavalent Antimonials Sales (g) by Company (2015-2020)
Table 63. Japan Pentavalent Antimonials Sales Market Share by Company (2015-2020)
Table 64. Japan Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 65. Japan Pentavalent Antimonials Sales Market Share by Type (2015-2020)
Table 66. Japan Pentavalent Antimonials Sales (g) by Application (2015-2020)
Table 67. Japan Pentavalent Antimonials Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pentavalent Antimonials Sales (g) by Company (2015-2020)
Table 69. Southeast Asia Pentavalent Antimonials Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 71. Southeast Asia Pentavalent Antimonials Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 73. Southeast Asia Pentavalent Antimonials Sales Market Share by Application (2015-2020)
Table 74. India Pentavalent Antimonials Sales (g) by Company (2015-2020)
Table 75. India Pentavalent Antimonials Sales Market Share by Company (2015-2020)
Table 76. India Pentavalent Antimonials Sales (g) by Type (2015-2020)
Table 77. India Pentavalent Antimonials Sales Market Share by Type (2015-2020)
Table 78. India Pentavalent Antimonials Sales (g) by Application (2015-2020)
Table 79. India Pentavalent Antimonials Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Pentavalent Antimonials Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 83. Sanofi Pentavalent Antimonials Product
Table 84. Sanofi Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Pentavalent Antimonials Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Pentavalent Antimonials Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Pentavalent Antimonials Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Pentavalent Antimonials Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. Maiden Pharmaceuticals Corporation Information
Table 96. Maiden Pharmaceuticals Description and Business Overview
Table 97. Maiden Pharmaceuticals Pentavalent Antimonials Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 98. Maiden Pharmaceuticals Pentavalent Antimonials Product
Table 99. Maiden Pharmaceuticals Recent Development
Table 100. Xinhua Pharm Corporation Information
Table 101. Xinhua Pharm Description and Business Overview
Table 102. Xinhua Pharm Pentavalent Antimonials Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 103. Xinhua Pharm Pentavalent Antimonials Product
Table 104. Xinhua Pharm Recent Development
Table 105. Albert David Corporation Information
Table 106. Albert David Description and Business Overview
Table 107. Albert David Pentavalent Antimonials Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 108. Albert David Pentavalent Antimonials Product
Table 109. Albert David Recent Development
Table . Science Direct Corporation Information
Table . Science Direct Description and Business Overview
Table . Science Direct Pentavalent Antimonials Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table . Science Direct Pentavalent Antimonials Product
Table . Science Direct Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Pentavalent Antimonials Distributors List
Table 118. Pentavalent Antimonials Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Pentavalent Antimonials Product Picture
Figure 2. Global Pentavalent Antimonials Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pentavalent Antimonials Market Share by Application in 2020 & 2026
Figure 6. Hospitals Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Pentavalent Antimonials Sales (g) Growth Rate (2015-2026)
Figure 10. Global Pentavalent Antimonials Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pentavalent Antimonials Price Trends Growth Rate (2015-2026) (USD/mg)
Figure 12. Global Pentavalent Antimonials Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pentavalent Antimonials Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pentavalent Antimonials Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pentavalent Antimonials Sales (g) Growth Rate (2015-2026)
Figure 16. Europe Pentavalent Antimonials Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pentavalent Antimonials Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pentavalent Antimonials Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pentavalent Antimonials Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pentavalent Antimonials Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pentavalent Antimonials Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pentavalent Antimonials Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pentavalent Antimonials Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pentavalent Antimonials Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pentavalent Antimonials Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pentavalent Antimonials Players Market Share by Revenue in Pentavalent Antimonials 2015 & 2019
Figure 27. Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pentavalent Antimonials Revenue Share by Type (2015-2020)
Figure 29. Global Pentavalent Antimonials Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pentavalent Antimonials Revenue Share by Application (2015-2020)
Figure 31. Global Pentavalent Antimonials Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pentavalent Antimonials Sales Market Share by Type in 2019
Figure 33. United States Pentavalent Antimonials Sales Market Share by Type in 2019
Figure 34. Europe Pentavalent Antimonials Sales Market Share by Company in 2019
Figure 35. Europe Pentavalent Antimonials Sales Market Share by Type in 2019
Figure 36. Europe Pentavalent Antimonials Sales Market Share by Application in 2019
Figure 37. China Pentavalent Antimonials Sales Market Share by Company in 2019
Figure 38. China Pentavalent Antimonials Sales Market Share by Type in 2019
Figure 39. China Pentavalent Antimonials Sales Market Share by Application in 2019
Figure 40. Japan Pentavalent Antimonials Sales Market Share by Company in 2019
Figure 41. Japan Pentavalent Antimonials Sales Market Share by Type in 2019
Figure 42. Japan Pentavalent Antimonials Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pentavalent Antimonials Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pentavalent Antimonials Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pentavalent Antimonials Sales Market Share by Application in 2019
Figure 46. India Pentavalent Antimonials Sales Market Share by Company in 2019
Figure 47. India Pentavalent Antimonials Sales Market Share by Type in 2019
Figure 48. India Pentavalent Antimonials Sales Market Share by Application in 2019
Figure 49. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Maiden Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Xinhua Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Albert David Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Science Direct Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Pentavalent Antimonials
Figure 58. Manufacturing Process Analysis of Pentavalent Antimonials
Figure 59. Pentavalent Antimonials Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
皮膚リーシュマニア症薬の世界市場レポート2020 A recently published report by QY Research titled Global Cutaneous Leishmaniasis Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provid…- パレコキシブナトリウムの世界市場レポート2020 A recently published report by QY Research titled Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically p…
- ワルファリンナトリウムの世界市場レポート2020 A recently published report by QY Research titled Global Warfarin Sodium (CAS 129-06-6) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provi…
- ブロムフェナクナトリウムの世界市場レポート2020 A recently published report by QY Research titled Global Bromfenac Sodium (CAS 91714-93-1) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically pr…
- スルファセタミドナトリウムの世界市場レポート2020 A recently published report by QY Research titled Global Sulfacetamide Sodium (CAS 127-56-0) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …